Particulate matter (PM) collected from mainstream tobacco smoke is a test article commonly used for in vitro genotoxicity and cytotoxicity testing of combustible tobacco products. However, little published data exists concerning the stability of PM. We completed a 2 year study to quantify the effect of PM storage at À80°C, on the genotoxicity and cytotoxicity of PM generated from 3R4F and M4A reference cigarettes. The Ames test, Micronucleus assay (MNvit), Mouse Lymphoma assay (MLA) and the Neutral Red Uptake assay (NRU) were used. The majority of M4A and 3R4F PMs were genotoxic and cytotoxic at the timepoints tested. Some minor but statistically significant differences were observed for stored versus freshly prepared PM, but the magnitude of changes were within the variability observed for repeat testing.
Introduction
Tobacco smoke is a complex and dynamic aerosol that consists of a particulate matter (PM) phase and a gas-vapour phase (GVP) (Scian et al., 2009) . Routine toxicological assessment of tobacco smoke commonly uses the PM fraction of the smoke aerosol. PM is easily collected from mainstream tobacco smoke by a variety of methods (Wan et al., 2009 ) and produces consistent and reproducible responses in vitro. In addition there is a history of use of PM in a variety of in vitro assays including the Neutral Red Uptake assay (NRU), the in vitro micronucleus (MNvit) and the Ames test extending over 30 years and more recently, the Mouse Lymphoma assay (MLA) (Bakland et al., 2005; CORESTA, 2004; Wan et al., 2009) .
Several guidelines such as those developed by the International Conference on Harmonisation (ICH, 2011) and Committee on Mutagenicity (COM, 2011) suggest using a battery of core in vitro assays for the detection of mutagenicity and potential for carcinogenicity. In the case of tobacco products, Health Canada require the Ames test, the MNvit and NRU data (Health Canada, 2005) . In the absence of specific regulatory guidelines, the CORESTA in vitro Toxicology Taskforce (CORESTA, 2004) recommend (i) a bacterial mutagenicity assay (Ames Salmonella mutagenicity assay); (ii) a mammalian cell assay for cytogenetics/mutation (MNvit, chromosome aberration assay or the MLA); and (iii) a cytotoxicity assay (NRU).
The OECD principles of GLP and compliance monitoring (OECD, 1998) section 6 specifies that the Sponsor must detail the expiry date, specific storage instructions and stability of the test article. For PM, limited information is available regarding these criteria, with the exception of a 1 month expiry date for PM when stored at À75°C and tested in the Ames test (Roemer et al., 2002) . The CORESTA in vitro Toxicology Task Force (CORESTA, 2004) recommend: (i) PM extracts should be stored at À70°C within one hour of extraction; (ii) extracts can be stored at À70°C for up to 4 years; (iii) extracts should not be refrozen once thawed. The scientific rationale to support these recommendations, however, has not been published. In order to characterise the effect of storage, we have commissioned a study on PM prepared from two reference cigarettes, 3R4F and M4A (Table 1 ). The PMs were stored at À80°C for approximately 2 years and tested at defined intervals in the Ames test, MNvit, MLA and NRU assay. Freshly prepared PM was generated and tested simultaneously for comparison. The outcome of this study provides scientific data to support a recommendation for the maximum storage time of PM at À80°C, i.e. an expiry date.
Materials and methods

Cigarettes
Two reference cigarettes were evaluated in this study. M4A, a 100% flue cured tobacco product (British American Tobacco's historical control) and 3R4F, a 'US style' blended product (University of Kentucky). Cigarette parameters are detailed in Table 1 .
Particulate matter preparation
All PMs were generated (according to ISO puffing parameters; 35 mL puff volume, taken over 2 s, every 60 s) and extracted in DMSO at British American Tobacco, Southampton, as previously described in McAdam et al., 2011 . All extracts were frozen at À80°C and transported to Covance Laboratories Ltd. UK on dry ice where upon receipt they were stored at À80°C. The choice of storage temperature was dictated by the transportation of PMs on dry ice (À78.5°C) and the need to avoid further fluctuations in storage temperature.
For the determination of storage effects, sufficient PM from 3R4F and M4A cigarettes were prepared at the beginning of the study to provide sufficient test article for the 2 year period. PMs were divided into 1 mL aliquots to avoid freeze-thawing. Fresh 3R4F and M4A PMs were prepared at 1 (T 1 ), 3 (T 3 ), 6 (T 6 ), 12 (T 12 ), 18 (T 18 ) and 24 (T 24 ) months, transported to Covance Laboratories Ltd. UK and stored as above. At each timepoint, 'fresh' PMs were subsequently tested within 10 days with the respective 'stored' PM.
In vitro toxicology testing
All in vitro toxicology testing was conducted at Covance Laboratories Ltd. UK. Appropriate positive and negative controls were used in each assay. Treatment conditions were selected based on responsiveness to tobacco products as described in Combes et al., 2012 . Where specified, the mammalian liver post-mitochondrial fraction (S9) (Mol Tox™) was used for metabolic activation.
Ames test
The Ames test was performed according to the principles of OECD Test Guideline 471 (OECD, 1997a). Pre-incubation was used with tester strains TA98, TA100 and TA1537, in the presence of 10% S9 mix, with three replicates per concentration.
MLA
The MLA used L5178Y cells, using a Microtitre Ò fluctuation technique, according to the principles of OECD Test Guideline 476 (OECD, 1997b) . Two replicates per concentration were assayed for 24 h.
MNvit
For the MNvit, PMs were tested according to the principles of OECD Test Guideline 487 (OECD, 2010) in V79 cells for 24 h, four replicates per concentration.
NRU
For the NRU assay, PMs were tested in Balb/c 3T3 cells, six replicates per concentration, based on guidance described in ICCVAM ''in vitro cytotoxicity methods for estimating starting doses for acute oral systemic toxicity testing'' (ICCVAM, 1996) . The PM concentration resulting in 50% toxicity in the NRU test (IC 50 ) were derived by Phototox Version 2 (OECD, 2004).
Statistics
Ames, MLA, MNvit
For each stored and fresh PM (M4A and 3R4F), assay, treatment condition and common concentration (on the linear part of the dose response curve), separate regression lines were fitted across time (T 0 , T 1 , T 3 , T 6 , T 12 , T 18 and T 24 months) to test whether there was a significant response across time (i.e. a significant slope). An analysis of covariance (ANCOVA) model was then applied to test whether the response with each stored PM compared to that with each fresh PM, by time interaction was significant (i.e. significantly non-parallel slopes). Data analysis were performed with SAS, Version 9.2 (SAS Institute Inc.: Cary, North Carolina, USA [2002] [2003] [2004] [2005] [2006] [2007] [2008] .
The resolving power of the assays used in this study have been evaluated to have a resolving power of 80% to detect a 30% difference with 3 and 4 replicates in the Ames test and MNvit, respectively, and between 18 to 85% difference in the MLA with 2 replicates. The NRU is able to detect 18-49% difference between PMs (Oldham et al., 2012) . 
Results and discussion
Ames test, MLA and MNvit
In all instances, PM concentrations were selected to provide data points on the linear portion of the dose response curve. The majority of PMs induced statistically significant (P 6 0.05) concentration dependent genotoxic responses in the Ames test, MLA and MNvit. However, at T 18 stored 3R4F and M4A, plus fresh 3R4F PM in Ames strain TA100 did not induce mutation. Stored M4A in TA1537 at T 18 also did not induce mutation. All non-inducing PMs were removed from analysis. At T 1 , stored 3R4F in the MLA at 30 lg/mL was also removed from analysis due to excessive heterogeneity between replicates, as determined by an F-test.
Stored 3R4F and M4A PMs were compared to their respective freshly prepared PMs using ANCOVA (Table 2) . Some statistically significant differences (P 6 0.05) were observed between stored and fresh M4A PMs in the Ames tester strain TA98 at 300 lg/plate (Table 2) . However, the linear regression analysis showed that the source of the difference was from fresh and not stored PM. Similar statistical differences were observed between stored and fresh 3R4F PMs in the MLA at 30 lg/mL (Table 2) . However, the observed differences are not consistent across all the doses analysed or both PMs (Table 2) . For all other concentrations analysed, there were no statistically significant differences between stored and fresh PMs. In addition, the data were combined for each storage condition, for each PM and each concentration analysed, in each assay over the 2 year period (Figs. 1-3 ). The figures demonstrate that the combined induced responses at the concentrations analysed were comparable between the stored and fresh samples. Therefore, differences in assay responses did not show any consistency or pattern that was indicative of a true time-related effect, and as such the sporadic differences were attributed to biological assay variability.
In vitro cytotoxicity assay
For each timepoint and PM, a concentration related decrease in cell viability was observed in the NRU, which allowed IC 50 values to be calculated. A lower IC 50 value indicates higher cytotoxicity. The IC 50 values for fresh and stored 3R4F PMs differed at each individual timepoint. However, there was no trend with time over the duration of the study. The same observation was made for fresh and stored M4A PMs. The differences observed were within the ranges of repeat testing of PMs (Fig. 4) .
The combined data for all timepoints (Fig. 4) indicate that there is no difference over time between fresh and stored samples with the variance overlapping for each PM.
Conclusion
The objective of this study was to determine whether storing 3R4F and M4A PMs at À80°C for 2 years affected the responses of the Ames test, MNvit, MLA and NRU assays. Stored and fresh PMs were tested in the in vitro assays at 7 timepoints over the 2 year period. We found that, when fresh and stored 3R4F and M4A PMs were compared on a dose-for-dose basis, the majority of concentrations analysed were not significantly different. Where differences were observed, they showed no consistent trends or patterns and therefore these differences were considered to be chance events that were due to normal biological variability within the assay combined with the multiplicity of testing.
It is concluded that, within the sensitivity and specificity of the assay systems used, PM can be stored for up to 2 years at À80°C without affecting its ability to induce genotoxicity or cytotoxicity. 
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